Sommaire
Littérature scientifique sur le sujet « N6-Isopentenyladenosine »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « N6-Isopentenyladenosine ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "N6-Isopentenyladenosine"
Fiore, Donatella, Chiara Piscopo, Maria Proto, Michele Vasaturo, Fabrizio Dal Piaz, Bruno Fusco, Cristina Pagano, Chiara Laezza, Maurizio Bifulco et Patrizia Gazzerro. « N6-Isopentenyladenosine Inhibits Colorectal Cancer and Improves Sensitivity to 5-Fluorouracil Targeting FBXW7 Tumor Suppressor ». Cancers 11, no 10 (28 septembre 2019) : 1456. http://dx.doi.org/10.3390/cancers11101456.
Texte intégralHASHIZUME, Takeshi, Wataru TANIGUCHI et Tamiji SUGIYAMA. « Mass spectrometric determination of N6-isopentenyladenosine and N6-isopentenyladenine from human urine. » Analytical Sciences 2, no 2 (1986) : 157–59. http://dx.doi.org/10.2116/analsci.2.157.
Texte intégralColombo, Francesca, F. Stefania Falvella, Loris De Cecco, Monica Tortoreto, Graziella Pratesi, Pierangela Ciuffreda, Roberta Ottria et al. « Pharmacogenomics and analogues of the antitumour agent N6-isopentenyladenosine ». International Journal of Cancer 124, no 9 (1 mai 2009) : 2179–85. http://dx.doi.org/10.1002/ijc.24168.
Texte intégralChmur, Magdalena, Andrzej Bajguz et Alicja Piotrowska-Niczyporuk. « Effect of Cadmium on the Level of Isoprenoid-Derived Phytohormones in Duckweed Wolffia arrhiza ». Journal of Plant Growth Regulation 39, no 4 (28 mai 2020) : 1518–30. http://dx.doi.org/10.1007/s00344-020-10154-9.
Texte intégralDassano, Alice, Mariateresa Mancuso, Paola Giardullo, Loris De Cecco, Pierangela Ciuffreda, Enzo Santaniello, Anna Saran, Tommaso A. Dragani et Francesca Colombo. « N6-isopentenyladenosine and analogs activate the NRF2-mediated antioxidant response ». Redox Biology 2 (2014) : 580–89. http://dx.doi.org/10.1016/j.redox.2014.03.001.
Texte intégralBifulco, Maurizio, Anna Malfitano, Maria Proto, Antonietta Santoro, Maria Caruso et Chiara Laezza. « Biological and Pharmacological Roles of N6-Isopentenyladenosine : An Emerging Anticancer Drug ». Anti-Cancer Agents in Medicinal Chemistry 8, no 2 (1 février 2008) : 200–204. http://dx.doi.org/10.2174/187152008783497028.
Texte intégralKierzek, Elżbieta, et Ryszard Kierzek. « Influence of N6-isopentenyladenosine (i6A) on thermal stability of RNA duplexes ». Biophysical Chemistry 91, no 2 (juillet 2001) : 135–40. http://dx.doi.org/10.1016/s0301-4622(01)00165-x.
Texte intégralRajabi, Mehdi, Jamshid Mehrzad, Elena Gorincioi et Enzo Santaniello. « Antiproliferative Activity of N6-Isopentenyladenosine on HCT-15 Colon Carcinoma Cell Line ». Nucleic Acid Therapeutics 21, no 5 (octobre 2011) : 355–58. http://dx.doi.org/10.1089/nat.2011.0314.
Texte intégralSpinola, Monica, Francesca Colombo, F. Stefania Falvella et Tommaso A. Dragani. « N6-isopentenyladenosine : A potential therapeutic agent for a variety of epithelial cancers ». International Journal of Cancer 120, no 12 (2007) : 2744–48. http://dx.doi.org/10.1002/ijc.22601.
Texte intégralLaezza, Chiara, Angelo Migliaro, Rosalba Cerbone, Idolo Tedesco, Mariarosaria Santillo, Corrado Garbi et Maurizio Bifulco. « N6-Isopentenyladenosine Affects cAMP-Dependent Microfilament Organization in FRTL-5 Thyroid Cells ». Experimental Cell Research 234, no 1 (juillet 1997) : 178–82. http://dx.doi.org/10.1006/excr.1997.3610.
Texte intégralThèses sur le sujet "N6-Isopentenyladenosine"
Picardi, Paola. « Novel Insights into the Biological Effects of the Isoprenoid Derivative N6-Isopentenyladenosine : Involvement of the Metabolic Sensor Ampk in Angiogenesis Inhibition ». Doctoral thesis, Universita degli studi di Salerno, 2014. http://hdl.handle.net/10556/1477.
Texte intégralN6-isopentenyladenosine (iPA) is a modified adenosine characterized by an isopentenyl chain derived by dimethylallyl pyrophosphate (DMAPP), an intermediate of the metabolic pathway of mevalonate, that is known to be deregulated in cancer. iPA is an endogenous isoprenoid-derived product present in mammalian cells as a free nucleoside in the cytoplasm, or in a tRNA-bound form, displaying well established pleiotropic biological effects, including a direct anti-tumor activity against several cancers. However, the precise mechanism of action of iPA in inhibiting cancer cell proliferation remains to be clarified. In this work, we investigated whether iPA could directly interfere with the angiogenic process, fundamental to cancer growth and progression, and if the growth and proliferation of human melanoma cells, known for their highly angiogenic phenotype, could be affected by the treatment with iPA. Finally, we investigated if iPA could have an immunomodulatory role targeting directly human natural killer (NK) cells, components of innate immunity that participate in immunity against neoplastic cells, in order to provide a cooperative and multifactorial mode of action of iPA to arrest cancer growth. To evaluate the potential involvement of iPA in angiogenesis, we employed human umbilical vein endothelial cells (HUVECs) as a suitable in vitro model of angiogenesis, by evaluating the viability, proliferation, migration, invasion, tube formation, and molecular mechanisms involved. Data were corroborated in mice by using a gel plug assay. iPA dose- and time-dependently inhibited all the neoangiogenesis stages, with an IC50 of 0.98 μM. We demonstrated for the first time that iPA was monophosphorylated into iPA 5'-monophosphate (iPAMP) by adenosine kinase (ADK) inside the cells. iPAMP is the active form that inhibits angiogenesis through the direct activation of AMP-kinase (AMPK). Indeed, all effects were completely reversed by pre-treatment with 5-iodotubercidin (5-Itu), an ADK inhibitor. The isoprenoid intermediate isopentenyl pyrophosphate (IPP), which shares the isopentenyl moiety with iPA, was ineffective in the inhibition of angiogenesis, thus showing that the iPA structure is specific for the observed effects. Thus, iPA is a novel AMPK activator and could represent a useful tool for the treatment of diseases where excessive neoangiogenesis is the underlying pathology... [edited by author]
XII n.s.
Rajabi, M. « ANTIPROLIFERATIVE ACTIVITY OF CYTOKININE DERIVATIVESAGAINST HCT-15 COLON AND MCF-7 BREAST CANCER CELLS:CELL CYCLE ANALYSIS AND BSA &DNA-BINDING STUDY ». Doctoral thesis, Università degli Studi di Milano, 2010. http://hdl.handle.net/2434/150047.
Texte intégralDenmon, Andria. « The Role of Base Modifications on Tyrosyl-tRNA Structure, Stability, and Function in Bacillus subtilis and Bacillus anthracis ». Thesis, 2013. http://hdl.handle.net/1911/71946.
Texte intégral